UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
The enhancing effects of selenomethionine on harmine in attenuating pathological cardiac hypertrophy via glycolysis metabolism Journal article
Chen, Qi, Wang, Wen Yan, Xu, Qing Yang, Dai, Yan Fa, Zhu, Xing Yu, Chen, Zhao Yang, Sun, Ning, Leung, Chung Hang, Gao, Fei, Wu, Ke Jia. The enhancing effects of selenomethionine on harmine in attenuating pathological cardiac hypertrophy via glycolysis metabolism[J]. Journal of Cellular and Molecular Medicine, 2024, 28(19), e70124.
Authors:  Chen, Qi;  Wang, Wen Yan;  Xu, Qing Yang;  Dai, Yan Fa;  Zhu, Xing Yu; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.3/5.0 | Submit date:2024/10/10
Cardiac Hypertrophy  Combination Therapy  Glycolysis Metabolism  Harmine  Selenomethionine  
Recent discoveries of the role of histone modifications and related inhibitors in pathological cardiac hypertrophy Journal article
Wu, Ke Jia, Chen, Qi, Leung, Chung Hang, Sun, Ning, Gao, Fei, Chen, Zhaoyang. Recent discoveries of the role of histone modifications and related inhibitors in pathological cardiac hypertrophy[J]. Drug Discovery Today, 2024, 29(2), 103878.
Authors:  Wu, Ke Jia;  Chen, Qi;  Leung, Chung Hang;  Sun, Ning;  Gao, Fei; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:6.5/7.3 | Submit date:2024/02/22
Chromatin Remodeling  Epigenetics  Heart Failure  Histone Modification  Pathological Cardiac Hypertrophy  
Leucine-zipper and sterile-α motif kinase (ZAK): A potential target for drug discovery Journal article
Chang,Yu, Zhang,Qingwen, Li,Zhengqiu, Ding,Ke, Lu,Xiaoyun. Leucine-zipper and sterile-α motif kinase (ZAK): A potential target for drug discovery[J]. Current Medicinal Chemistry, 2016, 23(33), 3801-3812.
Authors:  Chang,Yu;  Zhang,Qingwen;  Li,Zhengqiu;  Ding,Ke;  Lu,Xiaoyun
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:3.5/4.0 | Submit date:2021/03/02
Cancer  Cardiac Hypertrophy  Inflammation  Mapk  Mlks  Zak  
Activation of peroxisome proliferator-activated receptor-α prevents glycogen synthase 3β phosphorylation and inhibits cardiac hypertrophy Journal article
Li R., Zheng W., Pi R., Gao J., Zhang H., Wang P., Le K., Liu P.. Activation of peroxisome proliferator-activated receptor-α prevents glycogen synthase 3β phosphorylation and inhibits cardiac hypertrophy[J]. FEBS Letters, 2007, 581(17), 3311-3316.
Authors:  Li R.;  Zheng W.;  Pi R.;  Gao J.;  Zhang H.; et al.
Favorite | TC[WOS]:38 TC[Scopus]:38 | Submit date:2018/12/21
Cardiac Hypertrophy  Glycogen Synthase Kinase  Nuclear Factor Of Activated t Cells  Peroxisome Proliferator-activated Receptor-α